Codex DNA (DNAY) Stock Highlights

1.84 | -6.6%

2023-02-09 01:39:21

Codex DNA Inc is a synthetic biology company focused on enabling researchers to rapidly, accurately, and reproducibly build or write high-quality synthetic DNA and mRNA that is ready to use in many downstream synthetic biology-enabled markets. It manufactures and sells laboratory equipment, specifically synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide.

Statistics

Range Today

1.8 2.03

Volume Today 23.68K

Range 1 Year

1.08 11.02

Volume 1 Year 67.12M

Range 3 Year

1.08 25.7

Volume 3 Year 118.88M

Range 10 Year

1.08 25.7

Volume 10 Year 118.88M

Highlights

Market Capitalization 38.38M (micro)

Current Price 1.84

Performance

Latest -6.6%

1 Month +15%

3 Months -4.17%

6 Months -18.58%

1 Year -79.49%

3 Years -90.8%

5 Years -90.8%

10 Years -90.8%

Benchmarks

Market Capitalization

81 / 92

Gross Profits

76 / 85

Total Revenue

0 / 89

Total Rank

17 / 92

Free Cashflow

0 / 90

Performance 5 years

79 / 92

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.